RPS6KA3

From Wikipedia, the free encyclopedia


Ribosomal protein S6 kinase, 90kDa, polypeptide 3
Identifiers
Symbol(s) RPS6KA3; RSK; CLS; HU-3; ISPK-1; MAPKAPK1B; MRX19; RSK2; S6K-alpha3; p90-RSK2; pp90RSK2
External IDs OMIM: 300075 MGI104557 HomoloGene37940
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 6197 110651
Ensembl ENSG00000177189 ENSMUSG00000031309
Uniprot P51812 P18654
Refseq NM_004586 (mRNA)
NP_004577 (protein)
NM_148945 (mRNA)
NP_683747 (protein)
Location Chr X: 20.08 - 20.19 Mb Chr X: 154.6 - 154.71 Mb
Pubmed search [1] [2]

Ribosomal protein S6 kinase, 90kDa, polypeptide 3, also known as RPS6KA3, is a human gene.[1]

This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin-Lowry syndrome (CLS).[1]

[edit] References

[edit] Further reading

  • Omary MB, Baxter GT, Chou CF, et al. (1992). "PKC epsilon-related kinase associates with and phosphorylates cytokeratin 8 and 18.". J. Cell Biol. 117 (3): 583–93. PMID 1374067. 
  • Ku NO, Omary MB (1994). "Identification of the major physiologic phosphorylation site of human keratin 18: potential kinases and a role in filament reorganization.". J. Cell Biol. 127 (1): 161–71. PMID 7523419. 
  • Adams MD, Kerlavage AR, Fleischmann RD, et al. (1995). "Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence.". Nature 377 (6547 Suppl): 3–174. PMID 7566098. 
  • Zhao Y, Bjørbaek C, Weremowicz S, et al. (1995). "RSK3 encodes a novel pp90rsk isoform with a unique N-terminal sequence: growth factor-stimulated kinase function and nuclear translocation.". Mol. Cell. Biol. 15 (8): 4353–63. PMID 7623830. 
  • Bjørbaek C, Vik TA, Echwald SM, et al. (1995). "Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene and analysis of coding regions and mRNA levels of the ISPK-1 and the protein phosphatase-1 genes in muscle from NIDDM patients.". Diabetes 44 (1): 90–7. PMID 7813820. 
  • Donnelly AJ, Choo KH, Kozman HM, et al. (1994). "Regional localisation of a non-specific X-linked mental retardation gene (MRX19) to Xp22.". Am. J. Med. Genet. 51 (4): 581–5. doi:10.1002/ajmg.1320510457. PMID 7943043. 
  • Moller DE, Xia CH, Tang W, et al. (1994). "Human rsk isoforms: cloning and characterization of tissue-specific expression.". Am. J. Physiol. 266 (2 Pt 1): C351–9. PMID 8141249. 
  • Xing J, Ginty DD, Greenberg ME (1996). "Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase.". Science 273 (5277): 959–63. PMID 8688081. 
  • Trivier E, De Cesare D, Jacquot S, et al. (1997). "Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome.". Nature 384 (6609): 567–70. doi:10.1038/384567a0. PMID 8955270. 
  • Paudel HK (1997). "Phosphorylation by neuronal cdc2-like protein kinase promotes dimerization of Tau protein in vitro.". J. Biol. Chem. 272 (45): 28328–34. PMID 9353289. 
  • Joel PB, Smith J, Sturgill TW, et al. (1998). "pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167.". Mol. Cell. Biol. 18 (4): 1978–84. PMID 9528769. 
  • Zheng-Fischhöfer Q, Biernat J, Mandelkow EM, et al. (1998). "Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.". Eur. J. Biochem. 252 (3): 542–52. PMID 9546672. 
  • Deak M, Clifton AD, Lucocq LM, Alessi DR (1998). "Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB.". EMBO J. 17 (15): 4426–41. doi:10.1093/emboj/17.15.4426. PMID 9687510. 
  • Du K, Montminy M (1999). "CREB is a regulatory target for the protein kinase Akt/PKB.". J. Biol. Chem. 273 (49): 32377–9. PMID 9829964. 
  • Hanger DP, Betts JC, Loviny TL, et al. (1998). "New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry.". J. Neurochem. 71 (6): 2465–76. PMID 9832145. 
  • Jacquot S, Merienne K, De Cesare D, et al. (1999). "Mutation analysis of the RSK2 gene in Coffin-Lowry patients: extensive allelic heterogeneity and a high rate of de novo mutations.". Am. J. Hum. Genet. 63 (6): 1631–40. PMID 9837815. 
  • Jacquot S, Merienne K, Pannetier S, et al. (1999). "Germline mosaicism in Coffin-Lowry syndrome.". Eur. J. Hum. Genet. 6 (6): 578–82. doi:10.1038/sj.ejhg.5200230. PMID 9887375. 
  • Smith JA, Poteet-Smith CE, Malarkey K, Sturgill TW (1999). "Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo.". J. Biol. Chem. 274 (5): 2893–8. PMID 9915826. 
  • Abidi F, Jacquot S, Lassiter C, et al. (1999). "Novel mutations in Rsk-2, the gene for Coffin-Lowry syndrome (CLS).". Eur. J. Hum. Genet. 7 (1): 20–6. doi:10.1038/sj.ejhg.5200231. PMID 10094187. 
  • Merienne K, Jacquot S, Pannetier S, et al. (1999). "A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation.". Nat. Genet. 22 (1): 13–4. doi:10.1038/8719. PMID 10319851.